Who are Arthrotec's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Aspirin.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/arthrotec.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Arthrotec — Competitive Intelligence Brief

Arthrotec (Diclofenac Sodium) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: diclofenac. Area: Oncology.

marketed diclofenac Acid-sensing ion channel 3 Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Arthrotec (Diclofenac Sodium) — Pfizer.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Arthrotec TARGET	Diclofenac Sodium	Pfizer	marketed	diclofenac	Acid-sensing ion channel 3	1988-01-01
Aspirin	acetylsalicylic acid	Bayer AG	marketed	NSAID, Antiplatelet agent	Gamma-glutamyltranspeptidase 1, Nicotinate phosphoribosyltransferase, Acid-sensing ion channel 3	1899-03-06

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2026-06-16 — Arthrotec · 8097651 · US
2026-06-16 — Arthrotec · 8927604 · US
2026-06-16 — Arthrotec · 9827197 · US
2026-06-16 — Arthrotec · 7759394 · US
2027-03-22 — Arthrotec · 8946292 · US
2027-10-17 — Arthrotec · 9168305 · US
2027-10-17 — Arthrotec · 9132110 · US
2027-10-17 — Arthrotec · 9101591 · US
2027-10-17 — Arthrotec · 9066913 · US
2027-10-17 — Arthrotec · 8871809 · US
2027-10-17 — Arthrotec · 8563613 · US
2027-10-17 — Arthrotec · 9539335 · US
2027-10-17 — Arthrotec · 9339552 · US
2027-10-17 — Arthrotec · 9339551 · US
2027-10-17 — Arthrotec · 9168304 · US
2027-10-17 — Arthrotec · 9220784 · US
2028-04-21 — Arthrotec · 8252838 · US
2029-02-24 — Arthrotec · 7662858 · US
2029-02-24 — Arthrotec · 7884095 · US
2029-02-24 — Arthrotec · 7939518 · US
2029-02-24 — Arthrotec · 8110606 · US
2029-02-24 — Arthrotec · 8623920 · US
2029-02-24 — Arthrotec · 9561200 · US
2029-07-10 — Arthrotec · 8741956 · US
2029-07-10 — Arthrotec · 8618164 · US
2029-07-10 — Arthrotec · 8217078 · US
2029-07-10 — Arthrotec · 9370501 · US
2029-07-10 — Arthrotec · 9415029 · US
2029-07-10 — Arthrotec · 9375412 · US
2030-04-23 — Arthrotec · 9017721 · US

Sponsor landscape (diclofenac class)

Pfizer · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Arthrotec — Competitive Intelligence Brief. https://druglandscape.com/ci/arthrotec. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab